AIDS Research and Human Retroviruses

Aims & Scope

AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS.

The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research, focusing on developments in prevention science, novel therapeutics, and immune-restorative approaches.

Cutting-edge papers on the latest progress and research advances through clinical trials and examination of targeted antiretroviral agents lead to improvements in translational medicine for optimal treatment outcomes.

AIDS Research and Human Retroviruses coverage includes: HIV cure research HIV prevention science - Vaccine research - Systemic and Topical PreP Molecular and cell biology of HIV and SIV Developments in HIV pathogenesis and comorbidities Molecular biology, immunology, and epidemiology of HTLV Pharmacology of HIV therapy Social and behavioral science Rapid publication of emerging sequence information.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.1
2024	1.50

Journal Rank

Year	Value
2024	10517

Journal Citation Indicator

Year	Value
2024	477

SJR (SCImago Journal Rank)

Year	Value
2024	0.554

Quartile

Year	Value
2024	Q3

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Identification of Breakpoints in Intergenotypic Recombinants of HIV Type 1 by Bootscanning

  Citation: 745

  Authors: MIKA O., JEAN K., DONALD S., FRANCINE E.

• A Modified Bootscan Algorithm for Automated Identification of Recombinant Sequences and Recombination Breakpoints

  Citation: 738

  Authors: D.P., D., K.A., C.

• Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization

  Citation: 467

  Authors: A., R., K., W., A., M., G., C., F., A., H.

• A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1

  Citation: 433

  Authors: Gabriela, Renate, Martin, Susanne, Regina, Franz, Hermann

• The CCR5 and CXCR4 Coreceptors—Central to Understanding the Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1 Infection

  Citation: 366

  Authors: John P., Scott G., Pavel, Jerome A.

• A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion

  Citation: 341

  Authors: Carl, Teresa, Thomas

• A General Model for the Transmembrane Proteins of HIV and Other Retroviruses

  Citation: 310

  Authors: WILLIAM R., JUDITH M., ROBERT F., MARK C., RONALD C.

• The HIV-1 Protease as a Therapeutic Target for AIDS

  Citation: 298

  Authors: CHRISTINE

• Lipid Rafts and HIV Pathogenesis: Host Membrane Cholesterol Is Required for Infection by HIV Type 1

  Citation: 297

  Authors: Zhaohao, Lisa M., Richard, Dzung H., James E.K.

• Virologic and Immunologic Determinants of Heterosexual Transmission of Human Immunodeficiency Virus Type 1 in Africa

  Citation: 297

  Authors: Ãœlgen Semaye, Susan A., Rosemary, Stan, Beatrice H., Heidi, Joseph, Francis, Sten H., Grace M.

---